0.jpg_thumb90

Ana Luz Quiroga Campano

Investigadora

Universidad de Chile

Santiago, Chile

Líneas de Investigación


Generación de valor estratégico de alto impacto para la industria biotecnológica chilena, mediante la optimización de bioprocesos: producción de vacunas veterinarias para la salmonicultura y cultivo de células humanas para medicina regenerativa

Educación

  •  Bioengineering, UNIVERSIDAD DE CHILE. Chile, 2010
  •  Chemical Engineering, UNIVERSIDAD DE CHILE. Chile, 2010
  •  Chemical Engineering, UNIVERSIDAD DE CHILE. Chile, 2012
  •  Chemical Engineering, IMPERIAL COLLEGE LONDON. Reino Unido, 2017

Experiencia Académica

  •   Investigadora Other

    UNIVERSIDAD DE CHILE

    Ingeniería

    Chile

    2017 - At present

  •   Postdoctoral Fellow Full Time

    GEORGIA INSTITUTE OF TECHNOLOGY

    Bioengineering

    Estados Unidos

    2019 - 2021

Experiencia Profesional

  •   Plant supervisor Full Time

    Aguas Andinas

    Santiago, Chile

    2011 - 2012

  •   Project engineer Full Time

    Aguas Andinas

    Sanitago, Chile

    2012 - 2012

  •   Senior scientist Full Time

    AstraZeneca

    Cambridge, Reino Unido

    2022 - At present

  •   Investigadora Part Time

    Universidad de Chile

    Chile

    2017 - At present

Formación de Capital Humano


Software : Statgraphics, gPROMS, SuperPro Design, MATLAB, MAPLE and AUTOCAD.
Programming languages : Java and Visual Basic (MS Office).
Laboratory techniques :Bacterial (E. coli) and mammalian cell culture (GS-NS0)
Batch and fed-batch operation in flasks and bioreactors (1-7 [L])
Microscopy, electrophoresis, HPLC (amino acid analysis and antibody quantification) and flow cytometry.



 

Article (3)

Energy-Based Culture Medium Design for Biomanufacturing Optimization: A Case Study in Monoclonal Antibody Production by GS-NS0 Cells
Advanced model-based control strategies for the intensification of upstream and downstream processing in mAb production
Experimental Validation of the Predictions of a Mathematical Model for Protein Purification and Tag Selection

ConferencePaper (2)

A Predictive Model for Energy Metabolism and ATP Balance in Mammalian Cells: Towards the Energy-Based Optimization of mAb Production
Development of advanced computational tools for the intensification of monoclonal antibody production

ConferencePoster (16)

Application of mechanistic preclinical PK/PD/efficacy modeling to support combination strategy for AZD9750, a novel oral androgen receptor degrader (PROTAC)
AZD4241, an orally bioavailable ERα PROTAC, degrades wild-type and mutant ERα and delivers anti-tumour activity in preclinical breast cancer models
Preclinical mechanistic PK/PD/Efficacy modeling for AZD4241, a novel oral estrogen receptor (ER) degrader (PROTAC), to support dose selection during early clinical development
The combination of the AR PROTAC AZD9750 and AKT inhibitor capivasertib delivers improved efficacy over monotherapy in prostate cancer
AZD9750, a novel androgen receptor proteolysis targeting chimera (AR-PROTAC) for the treatment of prostate cancer
Celia: a Model Based Platform for Media and Feeding Strategy Design for Improved Process Metrics
Preclinical mechanistic PK/PD-efficacy modeling for AZD9750, a novel oral androgen receptor degrader (PROTAC), to support dose selection during early clinical development
Validation of the CELIA Platform: Design and Optimization of Culture Media and Feeding Strategies for Mammalian Cell-Based Biomanufacturing Processes
Validation of the Model-based Cell Culture Media Design Platform “CELIA” for Biomass and Product Optimization in a Bioreactor Setting
Development of a model-based cell culture media design platform for biomass and product optimization: current results and future perspective
Incremento de biomasa en procesos de manufactura de biofármacos en Chile mediante estrategias de alimentación, diseño y optimización de medios de cultivo con la Plataforma CELIA
Cell composition determination of industrially relevant cell lines for a media design platform
Bioprocess Optimizer: Culture media optimization platform for manufacturing bio-products
Quantification methodology of cellular compounds as input of a novel platform for cell culture media design
Personalized and optimized low-dose and intensive chemotherapy treatments for patients with Acute Myeloid Leukemia (AML)
Dynamic optimization of the production of monoclonal antibodies in semi-batch operation

Proyecto (2)

Validación de plataforma CELIA: diseño y optimización de medios de cultivo y estrategias de alimentación para bioproceso
Plataforma para el diseño de medios de cultivo: optimización de la manufactura de bio-productos
3
Carolina Shene

TITULAR PROFESSOR

CHEMICAL ENGINEERING

UNIVERSIDAD DE LA FRONTERA

TEMUCO, Chile

2
Maria Lienqueo

FULL PROFESSOR

OF CHEMICAL AND BIOTECHNOLOGY ENGINEERING

UNIVERSIDAD DE CHILE

Santiago, Chile

2
Maria Salazar

Profesora Asociada

Ingeniería Química Biotecnología y Materiales

UNIVERSIDAD DE CHILE, FAC. DE CIENCIAS FÍSICAS Y MATEMATICAS DEPTO. INGENIERÍA QUÍMICA

Santiago, Chile

1
José Salgado

Associate Professor

Chemical Engineering, Biotechnology and Materials

UNIVERSIDAD DE CHILE

Santiago, Chile

2
Juan Asenjo

Professor

CHEMICAL AND BIOTECHNOLOGY ENGINEERING

University of Chile

SANTIAGO, Chile

23
Ana Quiroga

Investigadora

IngenieríaDepartamento de Ingeniería Química, Biotecnología y Materiales

Universidad de Chile

Santiago, Chile